1.Apoptosis of hypertrophic scar fibroblasts induced by HMME-PDT
Cai HONG ; Gu YING ; Zeng JING ; Zhao GUANG
Chinese Journal of Medical Aesthetics and Cosmetology 2011;17(5):381-384
Objective To investigate the apoptotic effects of hypertrophic scar fibroblast (HSF) induced by HMME-PDT.Methods Fibroblasts were cultured from nontreated hypertrophic scars,and cells at passages 4-6 were used for the experiments (photosensitizer dose 4 μg/ml,λ630 nm,pow er density 10 mw/cm2,energy fluence 2.5 J/cm2).Morphological and biochemical changes in fibroblasts were assessed by Hoechst 33258 staining and fluorescence microscopy.The rate of apoptotic or necrotic cells was detected by flow cytometry (FCM) through double staining of Annexin V -FITC and popodium iodide (PI),respectively.Results Marked morphological features of cell apoptosis were viewed under the fluorescent microscope through Hoechst 33258 staining.The analysis of FCM indica ted that the apoptotic rate was significantly increased after HMME PDT [(34.82 ± I.42) % vs (3.12±0.28) %,P<0.05],and apoptotic rate was higher than necrosis rate [(14.65±1.02) % vs (34.82±1.42) %,P<0.05].Conclusions Low level exposure to 630 nm PDT mediated by HMME appears to induce fibroblast apoptosis.
3.Anthocyanidin inhibits immunoglobulin E-mediated allergic response in mast cells.
Guang-Ri JIN ; Hai HONG ; Guang-Yu JIN ; Ying-Zhe LI ; Guang-Zhao LI ; Guang-Hai YAN
Acta Pharmaceutica Sinica 2012;47(1):34-38
This study is to investigate the anti-allergic effect of anthocyanidin and to explore its possible mechanism. The experiments of passive cutaneous anaphylaxis reaction (PCA) and colorimetry were used to determine the effect of anthocyanidin on degranulation of mast cells in vivo. For in vitro study, various concentrations of anthocyanidin (100, 50 and 25 micromol x L(-1)) were added to the culture medium of mast cells cultured with 100 microg x L(-1) of dinitrophenyl (DNP) specific IgE overnight. The azelastine (100 micromol x L(-1)) was selected as the positive control. The antigen (DNP-human serum albumin, DNP-HAS)-induced release of degranulation was measured by enzymatic assay, histamine was determined by EIA, and interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) were measured by Western blotting, separately. In addition, the effects of anthocyanidin on phosphorylation of NF-kappaB, p38MAPK and Akt were observed by Western blotting. The results showed that treatments with anthocyanidin (100 and 50 mg x kg(-1)) were followed by a decrease in PCA of rats. Anthocyanidin (100 and 50 micromol x L(-1)) obviously suppressed the degranulation from mast cells, whereas results from anthocyanidin (100 and 50 micromol x L(-1)) group indicated significant inhibitory effect on histamine, the calcium uptake, TNF-alpha, IL-6, phosphorylation of NF-kappaB, p38MAPK and Akt of mast cells induced by antigen. Anthocyanidin may suppress the anaphylactic reaction by inhibiting the action of mast cells. NF-kappaB, p38MAPK and Akt at least in part contribute to this event.
Animals
;
Anthocyanins
;
pharmacology
;
Anti-Allergic Agents
;
pharmacology
;
Calcium
;
metabolism
;
Cell Degranulation
;
drug effects
;
Histamine Release
;
drug effects
;
Immunoglobulin E
;
immunology
;
Interleukin-6
;
metabolism
;
Male
;
Mast Cells
;
immunology
;
metabolism
;
physiology
;
Passive Cutaneous Anaphylaxis
;
drug effects
;
Proto-Oncogene Proteins c-akt
;
metabolism
;
Random Allocation
;
Rats
;
Rats, Sprague-Dawley
;
Signal Transduction
;
Transcription Factor RelA
;
metabolism
;
Tumor Necrosis Factor-alpha
;
metabolism
;
p38 Mitogen-Activated Protein Kinases
;
metabolism
4.Clinical study of electro-acupuncture treatment with different intensities for functional constipation patients.
Fan, XIONG ; Ying, WANG ; Shi-Qi, LI ; Man, TIAN ; Cui-Hong, ZHENG ; Guang-Ying, HUANG
Journal of Huazhong University of Science and Technology (Medical Sciences) 2014;34(5):775-81
Functional constipation (FC) is a common functional bowel disorder disease that affects life quality of a large number of people. This study aimed to explore the impact of different intensities of electro-acupuncture (EA) treatment for FC patients. Totally, 111 patients with FC meeting the Rome III criteria were randomly assigned to different intensities of EA groups (low and high intensity of EA groups) and medicine-controlled (MC) group. In EA groups, patients were treated with EA at quchi (LI11) and shangjuxu (ST37) bilaterally for 4 weeks, 5 times/week in the first 2 weeks, and 3 times/week in the last 2 weeks. In MC group, 5 mg mosapride citrate was administered orally 3 times/day for 4 weeks. Spontaneous bowel movement frequency each day was recorded using a constipation diary. Self-rating anxiety scale (SAS) and self-rating depression scale (SDS) were used to assess the patients' psychological state. Cortisol (CORT), substance P (SP), and vasoactive intestinal polypeptide (VIP) were evaluated at baseline and at the end of 4 weeks after treatment. As compared with the baseline, there was statistically significant increase in stool frequency every week (P<0.01), but there was no statistically significant difference among the three groups. As compared with the baseline, after 4 weeks of EA therapy, the scores of SDS and serum levels of CORT were decreased significantly in low intensity of EA group (P<0.01), and the serum levels of SP and VIP were increased significantly (P<0.05); the scores of SAS and SDS and serum levels of CORT were decreased significantly in high intensity of EA group (P<0.05), and the serum levels of SP and VIP were increased significantly (P<0.05); the serum levels of CORT and VIP were increased significantly in MC group (P<0.05). As compared with MC group, after 4 weeks of treatment, the serum levels of SP were signifcicantly increased in low intensity of EA group (P<0.01). Low and high intensities of EA could increase the stool frequency, improve the FC patient's anxiety and depression, reduce the serum levels of CORT, and increase the serum levels of SP and VIP effectively. It is concluded that both low and high intensities of EA are effective for FC patients, but there is no significant difference between the low and high intensities of EA.
6.Study of the antiulcer effect of pantoprazole
Ying-Xin WANG ; Xiao-Qiang LI ; Guang-Wu WU ; Shan-Jun QIAN ; Hong LEI ; Chang CAO ;
Chinese Journal of Clinical Pharmacology and Therapeutics 1999;0(04):-
Aim To evaluate the effects of pantoprazole on various experimental acute ulcer inrats and mice. Methods The model of a gastric ulcer of rats or mice was caused bystree- induced ulcer and ligatel pylurus-induced ulcer. Results & Conclusions At adose of 5, 10, 20 mg? kg-1 of Pantoprazole can markedly decrease the ulcer index ofstree-induced ulcer. Pantoprazole(4, 8, 16 mg? kg -1 ) significantly decrease the areaof ligated pylorus-induced gastric ulcer. It was also found that pantoprazole caninhibit the output of basic gastric acid.
7.Two-step Tandem Chromatography Purification of Anti-human CD80 Monoclonal Antibody 4E5 from Mouse Ascites
Hong-Bing MA ; Yu-Hua QIU ; Ran TAO ; Wen-Xiang LI ; Ying XU ; Xue-Guang ZHANG ;
China Biotechnology 2006;0(08):-
A two-step method for the purification of blocking-type anti-human CD80 monoclonal antibody 4E5 from mouse ascites was developed using anion exchange and gel filtration in combination. The ascites was first purified by anion exchange after centrifugation and filtration. The experimental parameters of sample loading and elution were optimized. The optimized loading condition was pH 8.0,50 mmol/L Tris-HCl and satisfactory results were obtained using a 0~0.5mol/L NaCl step elution. The fraction containing the protein of interest was directly loaded on gel filtration column and eluted using a 20 mmol/L phosphate buffer at pH 7.2. The purity of the obtained monoclonal antibody was up to 95% with a recovery of 61%. The purity of mAb could efficiently inhibit the growth of Daudi cells. The amplification of the method was also studied using a Bio-Scale Q5 column and the result was satisfied.
8.Comparison of the characteristics of coronary artery disease between first-degree relatives and non-first-degree relatives of patients with type 2 diabetes
Weiqiong GU ; Yifei ZHANG ; Jie HONG ; Ying CHEN ; Yu ZHANG ; Yuwen ZHANG ; Xiaoying LI ; Guang NING
Chinese Journal of Endocrinology and Metabolism 2009;25(4):374-377
y screen and prevent CAD in these people before diabetes sets in.
9.Type 1 diabetes mellitus and stroke
Hong CHANG ; Haixia GAO ; Ying CHANG ; Guang SHI ; Yu YANG ; Jianghui WANG
International Journal of Cerebrovascular Diseases 2015;23(4):286-289
Many studies have shown that the incidence of type 1 diabetes mellitus (T1DM) is increasing with an annual of 2% to 5%.As the same with type 2 diabetes mellitus,T1DM is also a risk factor for stroke.Although some T1DM studies have taken stroke as a component of the composite endpoint of cardiovascular events,a few studies have focused on the risk of stroke in patients with T1DM.Recent studies have shown that the risk of stroke in patients with T1DM is significantly higher than those without diabetes mellitus,especially in the population under the age of 50.In addition,the T1DM patients died of the risk of stroke are 3 to 4 times higher than the general population.This article reviews the relationship between T1DM and stroke.
10.Roles of statins in the prevention of ischemic stroke
Hong CHANG ; Ying CHANG ; Guang SHI ; Yu YANG ; Jianghui WANG ; Haixia GAO
International Journal of Cerebrovascular Diseases 2015;23(1):65-70
Effective prevention is the best approach for reducing the burden of stroke.The reduction of low-density lipoprotein cholesterol with statins may decrease the risks of patients with the first ever stroke and ischemic stroke or recurrent stroke in patients with transient ischemic attack.In stroke prevention,the treatment of statins has become the most important advance following aspirin and antihypertensive treatment.This article reviews the roles of statins in the prevention of stroke.